Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FONR - US3444374058 - Common Stock

14.2 USD
+0.13 (+0.92%)
Last: 11/25/2025, 8:00:00 PM
14.2 USD
0 (0%)
After Hours: 11/25/2025, 8:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FONR. FONR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.
FONR had a positive operating cash flow in the past year.
Each year in the past 5 years FONR has been profitable.
FONR had a positive operating cash flow in each of the past 5 years.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1.2 Ratios

FONR's Return On Assets of 3.20% is fine compared to the rest of the industry. FONR outperforms 77.13% of its industry peers.
FONR has a Return On Equity of 4.00%. This is in the better half of the industry: FONR outperforms 75.53% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.80%, FONR is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FONR is below the industry average of 8.71%.
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROIC 3.8%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

FONR has a Profit Margin of 6.63%. This is in the better half of the industry: FONR outperforms 78.19% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 9.66%, FONR is doing good in the industry, outperforming 77.13% of the companies in the same industry.
In the last couple of years the Operating Margin of FONR has declined.
The Gross Margin of FONR (41.07%) is worse than 65.43% of its industry peers.
In the last couple of years the Gross Margin of FONR has declined.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.
FONR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FONR has been reduced compared to 5 years ago.
FONR has a better debt/assets ratio than last year.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

FONR has an Altman-Z score of 2.76. This is not the best score and indicates that FONR is in the grey zone with still only limited risk for bankruptcy at the moment.
FONR's Altman-Z score of 2.76 is fine compared to the rest of the industry. FONR outperforms 68.62% of its industry peers.
The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, FONR belongs to the top of the industry, outperforming 94.15% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that FONR is not too dependend on debt financing.
FONR's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. FONR outperforms 74.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 2.76
ROIC/WACC0.44
WACC8.65%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

A Current Ratio of 8.62 indicates that FONR has no problem at all paying its short term obligations.
The Current ratio of FONR (8.62) is better than 90.96% of its industry peers.
FONR has a Quick Ratio of 8.46. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 8.46, FONR belongs to the best of the industry, outperforming 90.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.62
Quick Ratio 8.46
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1

3. Growth

3.1 Past

FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.59%.
Measured over the past 5 years, FONR shows a small growth in Earnings Per Share. The EPS has been growing by 0.90% on average per year.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.36%.
The Revenue has been growing slightly by 4.02% on average over the past years.
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.65, FONR is valued correctly.
Based on the Price/Earnings ratio, FONR is valued cheaply inside the industry as 88.30% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.98, FONR is valued a bit cheaper.
Industry RankSector Rank
PE 13.65
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaply inside the industry as 98.40% of the companies are valued more expensively.
93.62% of the companies in the same industry are more expensive than FONR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.04
EV/EBITDA 3.59
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)15.16
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FONR!.
Industry RankSector Rank
Dividend Yield N/A

FONAR CORP

NASDAQ:FONR (11/25/2025, 8:00:00 PM)

After market: 14.2 0 (0%)

14.2

+0.13 (+0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-17 2025-11-17
Earnings (Next)02-16 2026-02-16
Inst Owners47.25%
Inst Owner Change-0.68%
Ins Owners5.07%
Ins Owner Change0%
Market Cap104.37M
Revenue(TTM)105.43M
Net Income(TTM)6.99M
Analysts0
Price TargetN/A
Short Float %0.43%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.65
Fwd PE N/A
P/S 0.99
P/FCF 14.04
P/OCF 9.24
P/B 0.6
P/tB 0.62
EV/EBITDA 3.59
EPS(TTM)1.04
EY7.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.01
FCFY7.12%
OCF(TTM)1.54
OCFY10.82%
SpS14.34
BVpS23.79
TBVpS22.77
PEG (NY)N/A
PEG (5Y)15.16
Graham Number23.6
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 4%
ROCE 5.05%
ROIC 3.8%
ROICexc 5.21%
ROICexgc 5.49%
OM 9.66%
PM (TTM) 6.63%
GM 41.07%
FCFM 7.05%
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 101.91%
Cap/Sales 3.67%
Interest Coverage 547.62
Cash Conversion 80.82%
Profit Quality 106.36%
Current Ratio 8.62
Quick Ratio 8.46
Altman-Z 2.76
F-Score5
WACC8.65%
ROIC/WACC0.44
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.09%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-21.49%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%

FONAR CORP / FONR FAQ

Can you provide the ChartMill fundamental rating for FONAR CORP?

ChartMill assigns a fundamental rating of 5 / 10 to FONR.


Can you provide the valuation status for FONAR CORP?

ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.


Can you provide the profitability details for FONAR CORP?

FONAR CORP (FONR) has a profitability rating of 5 / 10.


How financially healthy is FONAR CORP?

The financial health rating of FONAR CORP (FONR) is 8 / 10.